These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16001533)

  • 1. [Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?].
    Sonntag F; Schöffski O; Hass B
    MMW Fortschr Med; 2005 Jun; 147(24):39. PubMed ID: 16001533
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic analysis of the treatment of heart failure with beta-blockers].
    Díez-Manglano J
    Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will beta-blockers save money?
    Heidenreich PA
    J Card Fail; 2005 Dec; 11(9):657-8. PubMed ID: 16360959
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost effectiveness of bisoprolol in heart failure. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study (CIBIS) for Germany].
    Schädlich PK; Paschen B; Brecht JG
    Med Klin (Munich); 1997 Aug; 92(8):499-504. PubMed ID: 9340476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current state of the art of cardiological emergency care and the DRG system in 2004].
    Steinbeck G
    MMW Fortschr Med; 2004 Apr; 146(15):28-9. PubMed ID: 15373017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 10. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness analysis of bisoprolol treatment for heart failure.
    Di Stasi F; Scalone L; De Portu S; Menditto E; Mantovani LG
    Ital Heart J; 2005 Dec; 6(12):950-5. PubMed ID: 16502708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of perioperative atrial fibrillation with betablockers in coronary surgery: betaxolol versus metoprolol.
    Iliuta L; Christodorescu R; Filpescu D; Moldovan H; Radulescu B; Vasile R
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):89-93. PubMed ID: 19372098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational pharmacoeconomics?
    Douglas B
    N Z Med J; 2007 Jun; 120(1255):U2569. PubMed ID: 17546114
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic impact of beta blockade in heart failure.
    Gregory D; Udelson JE; Konstam MA
    Am J Med; 2001 May; 110 Suppl 7A():74S-80S. PubMed ID: 11334781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Added organ protection at little cost. Double savings with ACE inhibitors].
    MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Costs and benefits of an education program for patients with ankylosing spondylitis as part of an inpatient rehabilitation programs-study design and first results].
    Krauth C; Rieger J; Bönisch A; Ehlebracht-König I
    Z Rheumatol; 2003; 62(Suppl 2):II14-6. PubMed ID: 14648082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol CR/XL in the treatment of chronic heart failure.
    Gattis WA
    Pharmacotherapy; 2001 May; 21(5):604-13. PubMed ID: 11349749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.